Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the exposure of Atazanavir 400 mg with Ritonavir 100
mg and with Efavirenz 600 mg compared to Atazanavir 300 mg with 100 mg without Efavirenz in
Healthy Subjects